Proceedings of the 2014 Winter Simulation Conference

[1]  G. Eslick,et al.  Diabetes increases the risk of breast cancer: a meta-analysis. , 2012, Endocrine-related cancer.

[2]  Robert C. Leachman.  The Engineering Management of Speed , 2012 .

[3]  Stephen W. Sorensen,et al.  Lifetime risk for diabetes mellitus in the United States. , 2003, JAMA.

[4]  R. Baker,et al.  Use of a mathematical model to evaluate breast cancer screening policy , 1998, Health care management science.

[5]  Eric J Feuer,et al.  A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. , 2006, Journal of the National Cancer Institute. Monographs.

[6]  John W. Fowler,et al.  Production Planning and Control for Semiconductor Wafer Fabrication Facilities - Modeling, Analysis, and Systems , 2013, Operations research / computer science interfaces series.

[7]  R. C. Leachman,et al.  A production planning methodology for semiconductor manufacturing based on iterative simulation and linear programming calculations , 1996 .

[8]  Reha Uzsoy,et al.  A review of production planning and scheduling models in the semiconductor industry , 1994 .

[9]  J. Manson,et al.  Diabetes, metformin, and breast cancer in postmenopausal women. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Stephen W. Sorensen,et al.  The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance , 2005, Annals of Internal Medicine.

[11]  Wen Ye,et al.  Use of secondary data to estimate instantaneous model parameters of diabetic heart disease: Lemonade Method , 2012, Inf. Fusion.

[12]  R. Holman,et al.  A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) , 2004, Diabetologia.

[13]  J D Habbema,et al.  The MISCAN simulation program for the evaluation of screening for disease. , 1985, Computer methods and programs in biomedicine.

[14]  R. R. Holman,et al.  UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82 , 2013, Diabetologia.

[15]  James C. Chen,et al.  Capacity requirements planning for twin Fabs of wafer fabrication , 2009 .

[16]  M. Evans,et al.  Understanding the inter‐relationship between improved glycaemic control, hypoglycaemia and weight change within a long‐term economic model , 2010, Diabetes, obesity & metabolism.

[17]  D. Meyersdorf,et al.  Cycle time reduction for semiconductor wafer fabrication facilities , 1997, 1997 IEEE/SEMI Advanced Semiconductor Manufacturing Conference and Workshop ASMC 97 Proceedings.

[18]  Robert C. Leachman,et al.  IMPReSS: An Automated Production-Planning and Delivery-Quotation System at Harris Corporation-Semiconductor Sector , 1996 .

[19]  Natasha K. Stout,et al.  Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .

[20]  John G. Carlson,et al.  Mixed model assembly simulation , 1992 .

[21]  R. Scharpf,et al.  Influence of Diabetes Mellitus Type 2 and Prolonged Estrogen Exposure on Risk of Breast Cancer Among Women in Armenia , 2011, Health care for women international.

[22]  Donghee Lee,et al.  Chronic disease modeling and simulation software , 2010, J. Biomed. Informatics.

[23]  M. Pike,et al.  Predictors of the timing of natural menopause in the Multiethnic Cohort Study. , 2008, American journal of epidemiology.

[24]  John W. Fowler,et al.  A survey of problems, solution techniques, and future challenges in scheduling semiconductor manufacturing operations , 2011, J. Sched..

[25]  D B Kopans,et al.  Breast cancer: computer simulation method for estimating optimal intervals for screening. , 1999, Radiology.

[26]  F. Vicini,et al.  Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. , 2011, International journal of radiation oncology, biology, physics.

[27]  Michael Shwartz,et al.  A Mathematical Model Used to Analyze Breast Cancer Screening Strategies , 1978, Oper. Res..

[28]  Reha Uzsoy,et al.  Production planning for semiconductor manufacturing via simulation optimization , 2011, Proceedings of the 2011 Winter Simulation Conference (WSC).

[29]  Stuart Bermon,et al.  Capacity Optimization Planning System (CAPS) , 1999, Interfaces.

[30]  Bülent Çatay,et al.  Tool capacity planning in semiconductor manufacturing , 2003, Comput. Oper. Res..

[31]  C. Bain,et al.  Breast cancer in the Thai Cohort Study: An exploratory case-control analysis , 2009, Breast.

[32]  P. Fowler,et al.  Managing high IC yields with short cycle times , 1995, GaAs IC Symposium IEEE Gallium Arsenide Integrated Circuit Symposium 17th Annual Technical Digest 1995.

[33]  R. Leachman,et al.  On Capacity Modeling for Production Planning with Alternative Machine Types , 1992 .

[34]  N. Shah,et al.  Second-Line Agents for Glycemic Control for Type 2 Diabetes: Are Newer Agents Better? , 2014, Diabetes Care.

[35]  Russell E. King,et al.  Combined DES/SD model of breast cancer screening for older women, II: screening-and-treatment simulation , 2014 .

[36]  Morton Klein,et al.  Surveillance Schedules for Medical Examinations , 1974 .

[37]  Wilco Burghout,et al.  Hybrid microscopic-mesoscopic traffic simulation , 2004 .

[38]  Deanna J. M. Isaman,et al.  A computer simulation model of diabetes progression, quality of life, and cost. , 2005, Diabetes care.

[39]  Volker Foos,et al.  The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making , 2004, Current medical research and opinion.

[40]  Chiuhsiang Joe Lin,et al.  Finite Capacity Requirements Planning with Equipment Capability and Dedication for Semiconductor Manufacturing , 2008 .

[41]  Mark D. Huffman,et al.  Cardiovascular Health Behavior and Health Factor Changes (1988–2008) and Projections to 2020: Results From the National Health and Nutrition Examination Surveys , 2012, Circulation.

[42]  A. Garber,et al.  AACE Comprehensive Diabetes Management Algorithm 2013. Endocrine Practice. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[43]  Damodar Y. Golhar,et al.  The just-in-time philosophy : a literature review , 1991 .

[44]  J D Habbema,et al.  A model for breast cancer screening , 1990, Cancer.

[45]  Benjamin Caballero,et al.  Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity Epidemic , 2008, Obesity.

[46]  Reha Uzsoy,et al.  A REVIEW OF PRODUCTION PLANNING AND SCHEDULING MODELS IN THE SEMICONDUCTOR INDUSTRY PART I: SYSTEM CHARACTERISTICS, PERFORMANCE EVALUATION AND PRODUCTION PLANNING , 1992 .

[47]  Harry J de Koning,et al.  The MISCAN-Fadia continuous tumor growth model for breast cancer. , 2006, Journal of the National Cancer Institute. Monographs.

[48]  Lars Mönch,et al.  Solving volume and capacity planning problems in semiconductor manufaturing: A computational study , 2008, 2008 Winter Simulation Conference.

[49]  Nilay D Shah,et al.  Optimizing the Start Time of Statin Therapy for Patients with Diabetes , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[50]  Karla Kerlikowske,et al.  Prospective breast cancer risk prediction model for women undergoing screening mammography. , 2006, Journal of the National Cancer Institute.

[51]  A. Farmer,et al.  Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control , 2012, Diabetes Care.

[52]  M. Ristic,et al.  Fine planning for supply chains in semiconductor manufacture , 2000 .

[53]  J. Willem,et al.  Risk of endometrial cancer after tamoxifen treatment of breast cancer , 1994, The Lancet.

[54]  Chiuhsiang Joe Lin,et al.  Capacity planning with capability for multiple semiconductor manufacturing fabs , 2005, Comput. Ind. Eng..

[55]  Brian T. Denton,et al.  Optimizing the simultaneous management of blood pressure and cholesterol for type 2 diabetes patients , 2014, Eur. J. Oper. Res..

[56]  N. Raghavan,et al.  Finite-capacity production planning algorithms for a semiconductor wafer fabrication facility , 2001 .

[57]  F. Robert Jacobs,et al.  MANUFACTURING PLANNING AND CONTROL SYSTEMS FOR SUPPLY CHAIN MANAGEMENT , 2004 .

[58]  Jaume Barceló,et al.  An approach to multiclass mesoscopic simulation based on individual vehicles for dynamic network loading , 2013, 16th International IEEE Conference on Intelligent Transportation Systems (ITSC 2013).

[59]  Michael Florian,et al.  Comparison of Three Methods for Dynamic Network Loading , 2001 .

[60]  Eliyahu M. Goldratt,et al.  What is this thing called theory of constraints and how should it be implemented , 1990 .

[61]  László Tabár,et al.  Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials , 1995 .

[62]  Lars Mönch,et al.  A Finite Capacity Production Planning Approach for Semiconductor Manufacturing , 2007, 2007 IEEE International Conference on Automation Science and Engineering.

[63]  Lars Mönch,et al.  Heuristic approaches for master planning in semiconductor manufacturing , 2012, Comput. Oper. Res..